M&A Deal Summary

Allergan Acquires ZELTIQ Aesthetics

On February 13, 2017, Allergan acquired medical products company ZELTIQ Aesthetics from Aisling Capital for 2.5B USD

Acquisition Highlights
  • This is Allergan’s 9th transaction in the Medical Products sector.
  • This is Allergan’s 6th largest (disclosed) transaction.
  • This is Allergan’s 23rd transaction in the United States.
  • This is Allergan’s 7th transaction in California.

M&A Deal Summary
Date 2017-02-13
Target ZELTIQ Aesthetics
Sector Medical Products
Buyer(s) Allergan
Sellers(s) Aisling Capital
Deal Type Add-on Acquisition
Deal Value 2.5B USD
Advisor(s) Guggenheim Securities (Financial)
Cooley (Legal)

Target

ZELTIQ Aesthetics

Pleasanton, California, United States
ZELTIQ Aesthetics, Inc. is a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform. ZELTIQ's first commercial product, the CoolSculpting® System, is designed to reduce unwanted fat. CoolSculpting is based on the scientific principle that fat cells are more sensitive to cold than the overlying skin and surrounding tissues.

Search 200,197 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Allergan

Parsippany, New Jersey, United States
Category Company
Founded 1956
Sector Life Science
Employees31,200
Revenue 15.8B USD (2018)
DESCRIPTION

Allergan is an integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. The Company was originally established in 1956 and is based in Parsippany, New Jersey.

DEAL STATS #
Overall 33 of 38
Sector (Medical Products) 9 of 11
Type (Add-on Acquisition) 26 of 31
State (California) 7 of 9
Country (United States) 23 of 27
Year (2017) 1 of 3
Size (of disclosed) 6 of 25
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-12-20 LifeCell

Branchburg, New Jersey, United States

LifeCell Corp. is a provider of applications in plastic and reconstructive surgeries and abdominal wall procedures.

Buy $2.9B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-06-07 Keller Medical

Stuart, Florida, United States

Keller Medical, Inc. is a medical device company and developer of the Keller Funnel®. The Keller Funnel is a cone-shaped, lubricated plastic funnel that reduces surgeon and patient contact during breast augmentation or reconstruction procedures. Keller Medical was founded in 2008 and is based in Stuart, Florida.

Buy -

Seller(S) 1

SELLER

Aisling Capital

New York, New York, United States

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2000
PE ASSETS 1.8B USD
Size Large
Type Sector Focused
DESCRIPTION

Aisling Capital is a private investment firm focused on opportunities in the healthcare and medical technology sectors. The Firm specifically looks to invest in companies developing and commercializing innovative healthcare products, services, and technologies. Aisling Capital looks to commit $20 to $50 million per investment and prefers to be the lead investor. Aisling will consider investing in both public and private companies. Aisling Capital raised its first fund in 2000. The Firm is based in New York City.

DEAL STATS #
Overall 30 of 41
Sector (Medical Products) 4 of 6
Type (Add-on Acquisition) 21 of 24
State (California) 8 of 13
Country (United States) 30 of 41
Year (2017) 1 of 2
Size (of disclosed) 1 of 12
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-01-02 BridgeBio

Palo Alto, California, United States

BridgeBio is an Orphan disease drug platform with a robust portfolio of transformative drug programs that address rare diseases across oncology, cardiology, dermatology, neurology, and endocrinology. BridgeBio was founded in 2015 and is based in Palo Alto, California.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-06-12 Miramar Labs

Sunnyvale, California, United States

Miramar Labs is a privately owned medical device company dedicated to launching the next generation energy modality to treat dermatologic medical conditions. Miramar Labs was founded in 2006 and is based in Sunnyvale, California.

Sell $20M
Mergr

Product

Company

Legal